Cargando…
In Vivo Enrichment of Diabetogenic T Cells
Dysfunctional T cells can mediate autoimmunity, but the inaccessibility of autoimmune tissues and the rarity of autoimmune T cells in the blood hinder their study. We describe a method to enrich and harvest autoimmune T cells in vivo by using a biomaterial scaffold loaded with protein antigens. In m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521861/ https://www.ncbi.nlm.nih.gov/pubmed/28396510 http://dx.doi.org/10.2337/db16-0946 |
_version_ | 1783252051930644480 |
---|---|
author | Thelin, Martin A. Kissler, Stephan Vigneault, Frederic Watters, Alexander L. White, Des Koshy, Sandeep T. Vermillion, Sarah A. Mooney, David J. Serwold, Thomas Ali, Omar A. |
author_facet | Thelin, Martin A. Kissler, Stephan Vigneault, Frederic Watters, Alexander L. White, Des Koshy, Sandeep T. Vermillion, Sarah A. Mooney, David J. Serwold, Thomas Ali, Omar A. |
author_sort | Thelin, Martin A. |
collection | PubMed |
description | Dysfunctional T cells can mediate autoimmunity, but the inaccessibility of autoimmune tissues and the rarity of autoimmune T cells in the blood hinder their study. We describe a method to enrich and harvest autoimmune T cells in vivo by using a biomaterial scaffold loaded with protein antigens. In model antigen systems, we found that antigen-specific T cells become enriched within scaffolds containing their cognate antigens. When scaffolds containing lysates from an insulin-producing β-cell line were implanted subcutaneously in autoimmune diabetes–prone NOD mice, β-cell–reactive T cells homed to these scaffolds and became enriched. These T cells induced diabetes after adoptive transfer, indicating their pathogenicity. Furthermore, T-cell receptor (TCR) sequencing identified many expanded TCRs within the β-cell scaffolds that were also expanded within the pancreata of NOD mice. These data demonstrate the utility of biomaterial scaffolds loaded with disease-specific antigens to identify and study rare, therapeutically important T cells. |
format | Online Article Text |
id | pubmed-5521861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-55218612018-08-01 In Vivo Enrichment of Diabetogenic T Cells Thelin, Martin A. Kissler, Stephan Vigneault, Frederic Watters, Alexander L. White, Des Koshy, Sandeep T. Vermillion, Sarah A. Mooney, David J. Serwold, Thomas Ali, Omar A. Diabetes Immunology and Transplantation Dysfunctional T cells can mediate autoimmunity, but the inaccessibility of autoimmune tissues and the rarity of autoimmune T cells in the blood hinder their study. We describe a method to enrich and harvest autoimmune T cells in vivo by using a biomaterial scaffold loaded with protein antigens. In model antigen systems, we found that antigen-specific T cells become enriched within scaffolds containing their cognate antigens. When scaffolds containing lysates from an insulin-producing β-cell line were implanted subcutaneously in autoimmune diabetes–prone NOD mice, β-cell–reactive T cells homed to these scaffolds and became enriched. These T cells induced diabetes after adoptive transfer, indicating their pathogenicity. Furthermore, T-cell receptor (TCR) sequencing identified many expanded TCRs within the β-cell scaffolds that were also expanded within the pancreata of NOD mice. These data demonstrate the utility of biomaterial scaffolds loaded with disease-specific antigens to identify and study rare, therapeutically important T cells. American Diabetes Association 2017-08 2017-04-10 /pmc/articles/PMC5521861/ /pubmed/28396510 http://dx.doi.org/10.2337/db16-0946 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | Immunology and Transplantation Thelin, Martin A. Kissler, Stephan Vigneault, Frederic Watters, Alexander L. White, Des Koshy, Sandeep T. Vermillion, Sarah A. Mooney, David J. Serwold, Thomas Ali, Omar A. In Vivo Enrichment of Diabetogenic T Cells |
title | In Vivo Enrichment of Diabetogenic T Cells |
title_full | In Vivo Enrichment of Diabetogenic T Cells |
title_fullStr | In Vivo Enrichment of Diabetogenic T Cells |
title_full_unstemmed | In Vivo Enrichment of Diabetogenic T Cells |
title_short | In Vivo Enrichment of Diabetogenic T Cells |
title_sort | in vivo enrichment of diabetogenic t cells |
topic | Immunology and Transplantation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521861/ https://www.ncbi.nlm.nih.gov/pubmed/28396510 http://dx.doi.org/10.2337/db16-0946 |
work_keys_str_mv | AT thelinmartina invivoenrichmentofdiabetogenictcells AT kisslerstephan invivoenrichmentofdiabetogenictcells AT vigneaultfrederic invivoenrichmentofdiabetogenictcells AT wattersalexanderl invivoenrichmentofdiabetogenictcells AT whitedes invivoenrichmentofdiabetogenictcells AT koshysandeept invivoenrichmentofdiabetogenictcells AT vermillionsaraha invivoenrichmentofdiabetogenictcells AT mooneydavidj invivoenrichmentofdiabetogenictcells AT serwoldthomas invivoenrichmentofdiabetogenictcells AT aliomara invivoenrichmentofdiabetogenictcells |